Hibiscus tea for Moms-to-Be: tiny study tests safety and taste
NCT ID NCT07175597
First seen Sep 30, 2025 · Last updated Jun 23, 2026 · Updated 34 times
Summary
This small pilot study tested whether a daily hibiscus drink is acceptable and safe for pregnant women in their second trimester. Ten women drank it for four weeks and reported how it tasted and whether they had any stomach issues. Researchers also checked blood pressure and other health markers before and after the trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANT WOMAN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
MEDOMAI
Cuernavaca, Morelos, 62280, Mexico
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hibiscus sabdariffa drink (containing anthocyanins)
What this could lead to
If successful, this could point toward a safe, natural way to support blood pressure in pregnancy.
What could go wrong
This is a very small pilot study with only 10 participants, so results may not apply to all pregnant women. It only tested short-term use and did not measure long-term safety.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.